Cardio Diagnostics shares surge 17.07% after-hours after announcing partnership with Aimil Ltd to expand globally.

Cardio Diagnostics Holdings Inc. surged 17.07% in after-hours trading following the announcement of a new partnership with Aimil Ltd, a firm co-founded by its CEO. The collaboration, which expands the company’s global reach in medical diagnostics, was highlighted as a strategic milestone, signaling enhanced market access and operational scalability. The move aligns with the stock’s upward trajectory, driven by investor optimism over expanded business prospects and potential revenue growth from international partnerships.